Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo

Vincent Gasparik, François Daubeuf, Muriel Hachet‐Haas, François Rohmer, Patrick Gizzi, Jacques Haiech, Jean‐Luc Galzi, Marcel Hibert, Dominique Bonnet, Nelly Frossard

ACS Medicinal Chemistry Letters · 2011 · 27 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Chalcone 4 (compound 1) is a small molecule that neutralizes the CXC chemokine CXCL12 and prevents it from acting on the CXCR4 and CXCR7 receptors. To overcome its poor solubility in aqueous buffers, we designed highly soluble analogues of compound 1, phosphate, l-seryl, and sulfate, all inactive by themselves on CXCL12 but when cleaved in vivo into 1, highly active locally at a low dose in a mouse airway hypereosinophilia model.

References

13